Benitec Biopharma Limited BNTC
9.59
(0.05)
(0.52%)
as of 25 Sep
- Market cap
- $336.2M
- P/E
- 0.0×
Follow BNTC
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jan '23 | Jun '22 | Jan '22 | Jun '21 | Jan '21 | Jun '20 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | 75.03 | 55.52 | 126.39 | 771.78 | 309.21 | 299.04 | 0.40 |
P/FCF ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | (1.37) | (0.83) | (1.95) | (6.69) | (3.54) | (4.32) | (0.01) |
P/B ratio |
— | — | — | 27.86 | 0.54 | 3.29 | 2.07 | 0.91 | 0.98 | 0.00 |
Price to Tangible BV |
— | — | — | 27.86 | 0.54 | 3.29 | 2.07 | 0.91 | 0.98 | 0.00 |
EV/Sales |
— | — | — | 45.62 | (60.90) | 79.50 | 370.71 | (25.20) | 9.42 | (93.60) |
EV/EBITDA |
— | — | — | 0.00 | 0.29 | 0.00 | 0.00 | 0.11 | 0.00 | 1.18 |
EV/Operating CF |
— | — | — | (0.19) | 0.29 | (0.37) | (0.73) | 0.12 | (0.05) | 1.27 |
EV/FCF |
— | — | — | (0.19) | 0.29 | (0.37) | (0.72) | 0.11 | (0.04) | 1.25 |
Quick Ratio |
33.70 | 54.32 | 10.39 | 0.64 | 0.64 | 1.61 | 1.61 | 14.47 | 14.46 | 8.68 |
Current Ratio |
34.00 | 54.67 | 10.49 | 0.94 | 0.94 | 1.90 | 1.90 | 15.05 | 15.05 | 9.52 |
Net Debt/EBITDA |
3.52 | 2.33 | 2.27 | 0.12 | 0.12 | 0.20 | 0.20 | 1.48 | 1.50 | 1.19 |
Debt/Assets |
0.15% | 0.50% | 0.00% | 6.36% | 6.36% | 9.36% | 9.36% | 0.00% | 0.00% | 1.84% |
Debt/Equity |
0.00 | 0.01 | 0.00 | 1.41 | 1.41 | 0.19 | 0.19 | 0.00 | 0.00 | 0.02 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 |
Operating CF/Net income |
0.36 | 0.62 | 0.87 | 0.92 | 0.92 | 0.87 | 0.87 | 0.92 | 0.92 | 0.91 |
Capex/Depreciation |
(1.81) | (0.27) | (2.06) | (0.01) | 0.00 | (0.08) | 0.00 | (0.96) | 0.00 | (0.49) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (33.21%) | (52.46%) | (94.29%) | (9,684.16%) | (1,268.61%) | (631.78%) | (159.08%) | (69.38%) | (91.79%) | (80.82%) | |
| (32.28%) | (49.96%) | (78.94%) | (438.22%) | (374.86%) | (304.84%) | (133.14%) | (64.93%) | (84.22%) | (70.93%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (3,759.96%) | 0.00% | (796.25%) |
Return on Tangible Assets |
(25.80%) | (39.15%) | (47.67%) | 12,075.31% | (5,374.18%) | (725.42%) | (554.95%) | (70.78%) | (70.05%) | (82.35%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 267.67 | 267.67 | 15.00 | 15.00 | 154.66 | 154.66 | 211.13 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 17,032.00% | 17,032.00% | 15,441.10% | 15,441.10% | 11,898.31% | 11,898.31% | 2,942.16% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 8,509.33% | 8,001.33% | 9,104.11% | 8,567.12% | 11,037.29% | 10,318.64% | 5,457.84% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 602.67% | 0.00% | 1,191.78% | 0.00% | 1,074.58% | 0.00% | 232.35% |
Graham Net Nets |
— | — | — | (0.09) | 1.67 | 0.18 | 0.42 | 1.05 | 0.94 | 234.50 |
Graham Number |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | (350.95%) | (964.43%) | (10,787.49%) | (4,570.62%) | (101.84%) | (36,610.47%) | (15,436.61%) |
Free Cash Flow Yield |
— | — | — | (318.10%) | (377.30%) | (168.37%) | (66.97%) | (71.55%) | (69.94%) | (18,911.28%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.05 | 0.05 | 0.15 | 0.13 | 0.23 | 0.20 | 340.00 |
Operating CF per Share |
(0.35) | (0.65) | (1.06) | (13.00) | (10.99) | (33.07) | (27.98) | (50.82) | (42.96) | (25,116.67) |
Capex per Share |
0.00 | 0.00 | (0.01) | 0.00 | 0.00 | (0.03) | 0.00 | (0.88) | 0.00 | (313.33) |
Free Cash Flow per Share |
(0.36) | (0.65) | (1.07) | (13.00) | (10.99) | (33.10) | (27.98) | (51.69) | (42.96) | (25,430.00) |
Cash per Share |
3.87 | 2.70 | 2.77 | 1.80 | 1.52 | 8.48 | 7.17 | 78.35 | 66.18 | 32,670.00 |
Shareholders Equity per Share |
3.80 | 2.69 | 2.57 | 0.15 | 0.12 | 6.00 | 5.07 | 79.25 | 66.98 | 34,126.67 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.80 | 2.69 | 2.57 | 0.15 | 0.12 | 6.00 | 5.07 | 79.25 | 66.98 | 34,126.67 |
Free Cash Flow |
(16.62) | (23.61) | (19.58) | (18.01) | (18.01) | (15.91) | (15.90) | (13.05) | (12.83) | (7.63) |
Working Capital |
176.34 | 96.72 | 46.75 | (0.25) | (0.25) | 2.29 | 2.29 | 19.24 | 19.24 | 9.67 |
Capital Expenditures |
(0.10) | (0.02) | (0.18) | 0.00 | 0.00 | (0.01) | (0.01) | (0.22) | (0.22) | (0.09) |
Net Current Asset Value |
176.08 | 96.22 | 46.71 | (0.53) | (0.53) | 1.73 | 1.73 | 19.24 | 19.24 | 9.46 |
EV/EBIT |
— | — | — | 0.00 | 0.29 | 0.00 | 0.00 | 0.11 | 0.00 | 1.14 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.18 | 0.00 | 3.75 | 0.00 | 0.92 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | (26,082.67%) | (26,082.67%) | (24,942.47%) | (24,942.47%) | (23,528.81%) | (23,528.81%) | (8,111.76%) |
Price to Operating Income |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.33 | 0.50 | 0.49 | 1.56 | 0.62 | 0.75 | 0.39 | 0.62 | 0.73 | 0.51 |
Cash ROIC |
(4.67%) | (12.12%) | (19.95%) | (608.17%) | (625.84%) | (214.46%) | (224.72%) | (33.19%) | (33.71%) | (39.05%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 1.36 | 2.59 | 24.33 | 5.21 | 2.36 | 1.40 | 1.73 |
Accounts Payable Turnover |
0.00 | 0.00 | (0.03) | 0.00 | 0.15 | 0.00 | 0.29 | 0.21 | 1.08 | (0.36) |
Inventory Turnover |
— | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | (14,076.16) | 0.00 | 3,095.32 | 76,244.44 | 1,711.22 | 2,611.38 | 182.83 | (1,461.97) |
Days of Inventory on Hand |
— | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.02 | 0.13 | 0.14 | 0.06 | 0.03 | 0.00 | 0.01 | 0.03 | 0.04 | 0.06 |
Average Payables |
2.66 | 2.59 | 3.70 | 3.23 | 2.56 | 1.88 | 1.38 | 0.58 | 0.51 | 0.51 |
Average Assets |
141.11 | 75.90 | 28.34 | 4.46 | 5.22 | 5.97 | 13.68 | 21.38 | 16.48 | 11.67 |
Average Common Equity |
137.15 | 72.27 | 23.73 | 0.20 | 1.54 | 2.88 | 11.45 | 20.01 | 15.12 | 10.24 |
Columns are period end dates